First License

Dow AgroSciences has received the world’s first registration for a plant-made vaccine --an innovation milestone for the company and the industry. The Dow AgroSciences Concert™ Plant-Cell-Produced System represents a new category of plant-made vaccines. This leading edge technology utilizes plant cells instead of whole plants in a secure, bio-contained environment to produce vaccines.

Read our news release or visit the FAQ for more information on this revolutionary new technology.